Synchron Company
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Industry:
Med Tech
Technology:
['BioTech & HealthTech']
Funding Status:
Late Stage Venture
Investment Stage:
N/A
Estimated Revenue:
$50M to $100M
Investors Number:
23.0
Headquarters:
Brooklyn, New York, United States
Employee Number:
1-10
Number Of Exists:
Series A
Investor Type:
Company
Total Funding:
130000000.0
Founded Date:
2016-04-01
Last Funding Type:
Series C
Last Funding Date:
2022-12-15